Results 171 to 180 of about 125,474 (196)

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen

Annals of Oncology, 2010
Emma Hall, Raoul Charles Coombes, J M Bliss   +2 more
exaly  

Tamoxifen-associated steatohepatitis - report of three cases

Journal of Hepatology, 1995
A Baptista, Miguel Carneiro de Moura
exaly  

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Annals of Oncology, 2010
Matteo Lazzeroni, Edoardo Botteri, S Mora   +2 more
exaly  

Tamoxifen Retinopathy

Journal of Neuro-Ophthalmology, 1998
openaire   +2 more sources

Tamoxifen

Reactions Weekly, 2022
openaire   +1 more source

Tamoxifen

Reactions Weekly, 2010
openaire   +2 more sources

Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

Annals of Oncology, 2005
Dirk Timmerman, L Ameye, R Paridaens
exaly  

Tamoxifen

Reactions Weekly, 2014
openaire   +2 more sources

Early discontinuation of tamoxifen

Cancer, 2007
Kathleen Bennett, Roisin M Connolly, Thomas I Barron   +2 more
exaly  

Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats

International Journal of Pharmaceutics, 2006
Jun-Shik Choi, Sang-Chul Shin
exaly